Adaptive Biotechnologies (ADPT) Retained Earnings (2018 - 2026)

Adaptive Biotechnologies has reported Retained Earnings for 9 years, with the latest figure at $1.6 billion in Q1 2026.

• Quarterly Retained Earnings rose 4.97% year-over-year to $1.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 4.97% YoY) and the FY2025 annual result came in at $1.6 billion, up 952820.48% from the prior year.
• Retained Earnings advanced to $1.6 billion in Q1 2026 per ADPT's latest filing, from $1.6 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $1.6 billion in Q1 2026 and troughed at -$1.2 billion in Q2 2024.
• A 5-year average of $464.1 million and a median of $1.3 billion in 2022 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings plunged 187.1% in 2024, then soared 952820.48% in 2025.
• Over 5 years, Retained Earnings stood at -$919.1 million in 2022, then surged by 100.02% to $215000.0 in 2023, then dropped by 22.79% to $166000.0 in 2024, then jumped by 952820.48% to $1.6 billion in 2025, then increased by 1.13% to $1.6 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $1.6 billion, $1.6 billion, and $1.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.